Congrats & so thrilled for @UCLAHealthJCCC @UCLAHealth @DOM_UCLA #bruinhearts @ucla_wic @A_SteinMerlob winning the #YIA at #GCOS2025! 🙏 to @alan_garfinkel, @uclaCVfellows @kewatson @IntMedAbel #STAR leadership for your amazing mentorship for this #cardioonc🌟! @ICOSociety

Look Carefully for Causes of Myocardial Infarction in Younger Patients: https://t.co/DitsnK5PXp @kewatson #CardioTwitter

Remarkable contributions to the field expanding a life saving therapy-great to see the two legends on the stage for 20th Annual VT Symposium- Mark Josephson Memorial Lecture. Our beloved Mark would indeed be smiling! @DrRoderickTung @VTSymposium

So lovely to spend time with some of our favorite people! Lovely to be able to have a hike & breakfast with @rblument1 & @WendyPost9 today before their wedding they are attending tonight & before @SmidtHeart GR on Tuesday! We loved being able to see you both! #CVPrev &

Amgen announced the Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints demonstrating that evolocumab significantly reduced the risk of MACE in individuals without a prior history of heart attack or stroke 12,000 high-risk patients, median of 4.5 years @kewatson

Data from the COMBINE-AF substudy suggest it may be safe and beneficial to switch frail older patients with atrial fibrillation from warfarin to a direct-acting oral anticoagulant. https://t.co/5zkcv5gIda #CardioTwitter @kewatson

Statins have been contraindicated during pregnancy because of teratogenic effects in animal studies. Now, using Norwegian registry data, researchers have evaluated statin exposure and congenital malformations in more than 800,000 pregnancies. https://t.co/5n0aiXgp2N @kewatson

A privilege to listen to GDMT masterclass with Dr Gregg Fonarow @gcfmd at @UCLA_HF Symposium Evidence, nuance, and practical takeaways for #HFmrEF #HFpEF care

@alxbenevides @ehj_ed @ESC_Journals @DrMarthaGulati @MihaiTrofenciuc @ShelleyZieroth @AnastasiaSMihai @purviparwani @SamRRazaMD @biljana_parapid @AlainBouchardmd @AliElzieny @kewatson convinced me, if a physiologic normal LDL-C is 20-40 mg/dL and Huygens and PACMAN-AMI demonstrate clear regression of plaque <40 mg/dL… then <<<40 mg/dL should be the optimal target. Stabilization and regression of plaque is the goal! @FamilyHeartFdn #FHFSummit25

A New Expert Consensus Document on Pericardial Diseases Dr. @kewatson summarizes key recommendations of an American College of Cardiology statement on diagnosis and management of pericarditis. https://t.co/bnpF5tvxFx #CardioTwitter #guidelines

Delighted to see the neglected Mineralocorticoid receptor ♥️ biology receive due ⭐️ For so many years my #discovery #research struggled to get funding for identifying mechanism of action in heart beyond aldo excess & now 🔦

We had a strong show out of first year fellows at the Los Angeles City Wide Cardiac Cath Conference hosted on 9/11/25. So thankful for our Interventional Cardiology department to invite all general fellows to attend!!

Dr. Karol Watson comments on a pooled analysis of participant-level data from six randomized controlled trials that compared intensive blood pressure control against standard blood pressure control. https://t.co/3re0s8usIY @kewatson #CardioTwitter

Throwback Thursday to one of our chief fellows, Dr. Chris Lee for presenting a fascinating case of Clozapine induced myocarditis at ESC. So proud of our #Bruinheart for representing us overseas! And although he may be missing the food in Spain, we’re so glad to have him back!

Still feeling 🔥 up from our inspiring faculty panel discussion last week! Our all-star faculty covered career pivots, authentic discovery, growth from failure, impostor syndrome, mentorship, and more with refreshing honesty. We are so grateful. Dream big, WIC 🫀✨

@AHAScience #Hypertension25 #GLs Session with Panel currently “Unpacking the 2025 @American_Heart @ACCinTouch High #BloodPressure Guideline: What’s New & What It Means for Your Practice” @kewatson provides a great summary of “12 🔑 Takeaways You Can't Miss”

Do patients with a normal ejection fraction still need a beta-blocker after myocardial infarction? https://t.co/ED00oovmnE @kewatson @NEJM #ESCCongress

Happy Labor Day! We are so grateful for our colleagues and co-fellows who are holding down the fort and working hard taking care of our patients today. It’s a Bruinheart family like no other!! ❤️🫀❤️

Fun sock and Farmers’ market Fridays!! Keeping the traditions alive at @OliveViewUCLA . Even our newest faculty member Dr. De La Rosa is excited to be a part of them! @UCLAHealth @ucla_wic @dgsomucla

New 2025 AHA/ACC BP Guidelines https://t.co/Q757Iu7CK6 my top ten takeaways 1)BP goal ≤130 /80, SBP ≤ 120 if risk for CVD (class 1) use single-pill combo to ↑ adherence & simplify Rx tighter control of HTN to lower dementia risk But avoid orthostatic hypotension (class1)